How is Gilenya doing?

Quote




































Anonymous said:
More like 1100 filled. 30% of which are for free.

So let's do some real math. This isn't enough to keep your bonus screwed salesforce working another year.
Click to expand...


I would like to know if all areas of the country are experiencing the majority of SRFs not turning into TRX credit for bonus? In the month of January I will only receive TRX credit for 4 of 10 SRFs. It could even be less if the SRFs not FDO yet never go through. Between GSP issues, PAP, Priorauth issues, patients declines, samples, etc. , it is hard to make a real bonus eventhough the SRFs are produced. There is a lot of money riding on each patient and I am surprised management doesn't realize most of the salesforce is disgruntled. Turnover will come after the June bonus payouts.
 






It's been stated 1000 times on this board you work for Novartis did you really expect anything different.

The co can sell 400,000 scripts of drug and you will still make nothing


Losers
 












Anonymous said:
It's been stated 1000 times on this board you work for Novartis did you really expect anything different.

The co can sell 400,000 scripts of drug and you will still make nothing


Losers
Click to expand...

Sorry but my area did really well lowest person made 15k 1st quarter. If your not happy leave, I bet 1000 people would be happy to fill your job
 












This a a totally bogus post! Gilenya is the wife of Richard (Dick) Gozinya a higher up in East Hanover office. We will find you and make sure that you are called on the carpet for making any disparaging remarks about Gilenya . . . . . . . such a sweet lady with so many attributes!
 






Anonymous said:
This a a totally bogus post! Gilenya is the wife of Richard (Dick) Gozinya a higher up in East Hanover office. We will find you and make sure that you are called on the carpet for making any disparaging remarks about Gilenya . . . . . . . such a sweet lady with so many attributes!
Click to expand...


Honestly, how's Gilenya doing ?

Heard NVS is having some difficult time lifting the sales, after an initial up-swing.

What are the hurdles ?

Too expensive ?
Not enough Safety Data ?
Scare of the new OIs - toxoplasmosis and encephalitis ?
Poor Phase 4 program ?
Bad Senior Management from both the US and Global ?
Lack of strategic direction ?
Strong competitors ?
 






Gilenya is not doing as well as we had hoped. Currently giving away the house to get MDs to try. Most are nervous about long term effects. Two opportunistic infections reported and a Dear Doctor letter sent out to all clinical sites. MCO coverage not very good due to high cost and some MCOs have started step edits for two failures before they will pay for G.
 






Anonymous said:
Honestly, how's Gilenya doing ?

Heard NVS is having some difficult time lifting the sales, after an initial up-swing.

What are the hurdles ?

Too expensive ?
Not enough Safety Data ?
Scare of the new OIs - toxoplasmosis and encephalitis ?
Poor Phase 4 program ?
Bad Senior Management from both the US and Global ?
Lack of strategic direction ?
Strong competitors ?
Click to expand...

Love the competition coming on our boards fishing for information. We are over 10,000 rx in 5 months. If you work for anyone but Teva dust off that resume
 




































Top Bottom
Back
Quote